Don Manarang
Family Medicine · Quincy, ILNPI 1205833860
Payments from drug & device makers
Across 100 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$671
- Indivior Inc.$153
- Lilly USA, LLC$146
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$96
- Novo Nordisk$95
- Amarin Pharma, Inc.$87
- plus $613 from 22 others
What the payments were for
- Food & beverage$1,861100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $671 |
| Indivior Inc. | 7 | $153 |
| Lilly USA, LLC | 7 | $146 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $96 |
| Novo Nordisk | 5 | $95 |
| Amarin Pharma, Inc. | 5 | $87 |
| Boehringer Ingelheim | 1 | $70 |
| Exact Sciences | 3 | $61 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Sumitomo Pharma America, Inc. | 3 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Gilead | 2 | $34 |
| Amgen | 2 | $32 |
| AstraZeneca | 1 | $30 |
| Sanofi-aventis U.S. LLC | 1 | $29 |
| GSK | 2 | $26 |
| Johnson & Johnson | 1 | $20 |
| Pfizer | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $20 |
| Bayer | 1 | $18 |
| Nevro Corp. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Philips North America LLC | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Novartis | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$1,861 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 73 | $236,632 |
| IngrezzaValbenazine Tosylate | 16 | $136,388 |
| EliquisApixaban | 260 | $82,175 |
| JardianceEmpagliflozin | 170 | $51,021 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 59 | $48,077 |
| MounjaroTirzepatide | 23 | $24,853 |
| TrulicityDulaglutide | 24 | $24,737 |
| OzempicSemaglutide | 20 | $20,281 |
| FarxigaDapagliflozin Propanediol | 65 | $18,779 |
| AptiomEslicarbazepine Acetate | 28 | $17,614 |
| LinzessLinaclotide | 23 | $14,574 |
| VascepaIcosapent Ethyl | 79 | $14,027 |
| RexultiBrexpiprazole | 19 | $13,394 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 19 | $12,756 |
| XareltoRivaroxaban | 42 | $12,315 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Xarelto | $20 | $248,947115 claims |
| PfizerEliquis | $20 | $82,175260 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Synjardy | $70 | $73,991212 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta | $26 | $63,92794 claims |
| Lilly USA, LLCMounjaro, Trulicity | $146 | $49,58947 claims |
| AstraZenecaFarxiga, Symbicort | $30 | $28,80397 claims |
| AbbVieLinzess, Namzaric, Restasis | $671 | $27,31659 claims |
| Novo NordiskOzempic | $95 | $20,28120 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $40 | $13,39419 claims |
| NovartisEntresto | $14 | $11,06320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Quincy
- Divya BatraQuincy$444K
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.